BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18593948)

  • 1. Phosphoinositide 3-kinase/AKT signaling can promote AIB1 stability independently of GSK3 phosphorylation.
    Ferrero M; Avivar A; García-Macías MC; Font de Mora J
    Cancer Res; 2008 Jul; 68(13):5450-9. PubMed ID: 18593948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha.
    Yang C; Li S; Wang M; Chang AK; Liu Y; Zhao F; Xiao L; Han L; Wang D; Li S; Wu H
    Mol Cancer; 2013 Mar; 12():21. PubMed ID: 23514585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PI3K and AIB1 interaction is involved in estrogen treated breast cancer cells.
    Li Z; Deng X; Wu G; Qiu R; Ju X; Wang Y; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):65-70. PubMed ID: 29808803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIB1 promotes DNA replication by JNK repression and AKT activation during cellular stress.
    Horiguchi K; Arai S; Nishihara T; Nishikawa J
    J Biochem; 2006 Sep; 140(3):409-19. PubMed ID: 16877447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.
    Mani A; Oh AS; Bowden ET; Lahusen T; Lorick KL; Weissman AM; Schlegel R; Wellstein A; Riegel AT
    Cancer Res; 2006 Sep; 66(17):8680-6. PubMed ID: 16951183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of dendritic Akt degradation by the ubiquitin-proteasome system for neuronal polarity.
    Yan D; Guo L; Wang Y
    J Cell Biol; 2006 Jul; 174(3):415-24. PubMed ID: 16864652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3.
    Chen S; Cao W; Yue P; Hao C; Khuri FR; Sun SY
    Cancer Res; 2011 Oct; 71(19):6270-81. PubMed ID: 21868755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A11 is involved in the regulation of the stability of cell cycle regulator p21(CIP1/WAF1) in human keratinocyte HaCaT cells.
    Foertsch F; Teichmann N; Kob R; Hentschel J; Laubscher U; Melle C
    FEBS J; 2013 Aug; 280(16):3840-53. PubMed ID: 23745637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
    Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
    Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
    Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
    BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
    Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT
    Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of FoxO signaling in human hepatoma cells by exposure to copper or zinc ions.
    Walter PL; Kampkötter A; Eckers A; Barthel A; Schmoll D; Sies H; Klotz LO
    Arch Biochem Biophys; 2006 Oct; 454(2):107-13. PubMed ID: 16973122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK3 beta-dependent phosphorylation of the alpha NAC coactivator regulates its nuclear translocation and proteasome-mediated degradation.
    Quélo I; Akhouayri O; Prud'homme J; St-Arnaud R
    Biochemistry; 2004 Mar; 43(10):2906-14. PubMed ID: 15005626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.
    Chien CD; Kirilyuk A; Li JV; Zhang W; Lahusen T; Schmidt MO; Oh AS; Wellstein A; Riegel AT
    J Biol Chem; 2011 Jul; 286(30):26813-27. PubMed ID: 21636853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells.
    Kida A; Kakihana K; Kotani S; Kurosu T; Miura O
    Oncogene; 2007 Oct; 26(46):6630-40. PubMed ID: 17486076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells.
    Failor KL; Desyatnikov Y; Finger LA; Firestone GL
    Mol Endocrinol; 2007 Oct; 21(10):2403-15. PubMed ID: 17595317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover.
    Li C; Liang YY; Feng XH; Tsai SY; Tsai MJ; O'Malley BW
    Mol Cell; 2008 Sep; 31(6):835-49. PubMed ID: 18922467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
    Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
    Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.
    Giamas G; Castellano L; Feng Q; Knippschild U; Jacob J; Thomas RS; Coombes RC; Smith CL; Jiao LR; Stebbing J
    Nucleic Acids Res; 2009 May; 37(9):3110-23. PubMed ID: 19339517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
    Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
    Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.